Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Clancy

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Pageof 3